Leveraging multi-cancer blood tests to improve diagnostic efficiency for patients with nonspecific signs and symptoms

Amit G Singal, Kathryn N Kurtzman, Matthew J Thompson
Future Oncol . 2024 Aug 28:1-5. doi: 10.1080/14796694.2024.2388505. Online ahead of print.
Most cancers (86% in the US) are not detected by recommended screening [Citation1] and often not diagnosed until symptoms arise.

Leveraging multi-cancer blood tests to improve diagnostic efficiency for patients with nonspecific signs and symptoms